
Most current scientific research focuses primarily on pharmacological methods of treating osteoporosis. Few researchers pay attention to the need to systematize preventive measures. One such measure is an appropriate diet. The intake of adequate nutrients can significantly improve bone mineral density and reduce the risk of developing the disease. The aim of this article was to analyze the available scientific literature on the efficacy and safety of the use of specific nutrients in patients with osteoporosis. This paper is a narrative review based on electronic databases (PubMed, ScienceDirect, Google Scholar), covering mainly literature from 2016–2026. A total of 87 carefully selected publications were included in the detailed analysis. The greatest body of evidence points to the potential positive effects of combined vitamin D and calcium supplementation. When calcium supplements are used as monotherapy, the possible negative effects of these compounds on the cardiovascular system should be taken into account. Excessive dietary phosphorus intake may have adverse effects on the skeletal system.
Introduction Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disorder associated with heart failure, arrhythmias, and an increased risk of sudden cardiac death (SCD). Functional status and the HCM Risk-SCD score are key parameters guiding management. This study assessed the relationship between functional status, comorbidity burden, and the HCM Risk-SCD score in patients with HCM. Material and methods This retrospective single-cohort study included 56 patients with HCM. The HCM Risk-SCD score was calculated according to the 2023 ESC guidelines. Patients were stratified by heart failure symptoms into asymptomatic (NYHA I) and symptomatic (NYHA II–III) groups, and by comorbidity burden into low (0–1) and high (≥2) groups. Assessed comorbidities included systemic hypertension, hyperlipidemia, coronary artery disease, chronic kidney disease, COPD, and type 2 diabetes. Results The median HCM Risk-SCD score was higher in asymptomatic than symptomatic patients (3.46% [IQR 2.38-4.44] vs. 2.07% [IQR 1.17-2.23]; p=0.005). No significant difference was observed between patients with low and high comorbidity burden (1.95% vs. 2.01%; p=0.765), and no correlation was found between the HCM Risk-SCD score and the number of comorbidities (rho=-0.07, p=0.607). Conclusions Asymptomatic patients with HCM had a higher estimated risk of SCD than symptomatic patients. The HCM Risk-SCD score appeared to be independent of comorbidity burden. This shows that HCM individuals with better clinical and functional status may be at higher risk of SCD.
Introduction Computer vision is a clinically deployed component of diagnostic radiology, supporting detection, classification/triage, and segmentation/quantification. International evidence is substantial but concentrated in high-resource systems, with a gap between technical accuracy and clinical utility. Poland launched a nationally coordinated diagnostic artificial intelligence (AI) rollout in 2025–2026 but is under-represented in this literature. This review summarises computer vision performance across main diagnostic tasks and describes Poland’s implementation context, centred on the Platforma Usług Inteligentnych (PUI). Methods A narrative review, reported in line with SANRA criteria, of PubMed/MEDLINE, Google Scholar, and Polish institutional and grey-literature sources published 2022–2026. Results Detection, classification/triage, and segmentation/quantification are best validated in chest, neurological, and breast imaging, largely overlapping with PUI’s five prioritised domains (chest computed tomography (CT), chest radiograph, mammography, brain CT/magnetic resonance imaging, skeletal radiograph). Clinical utility and outcome evidence remains scarcer than accuracy data. PUI is funded through the EU-backed Krajowy Plan Odbudowy; vendors were selected in all five model areas, but routine production use after the 30 June 2026 deadline was unconfirmed (as of 19 October 2026). PUI responds to workload growth and regional and subspecialty distribution among fewer than 4,600 radiologists (about 123 per million; EU average 127), not to a per-capita deficit. In a national survey, 4.7% of institutions used AI, 33.9% of them in CT. Published Polish evidence on diagnostic AI remains limited. Conclusions PUI enters a technically well-evidenced field but is a live test of the under-studied validation gap, offering Polish radiology a substantial opportunity to contribute original evidence.
Introduction Deventilation syndrome (DVS), defined as increased dyspnoea after cessation of prolonged non-invasive ventilation (NIV), remains a diagnostic and therapeutic challenge. Knowledge of its pathophysiology, prevalence and treatment is limited. This study aimed to characterise patients receiving home NIV, determine DVS prevalence and explore associated factors. Material and methods This nationwide questionnaire-based observational study included patients treated within a home NIV programme and their attending physicians. DVS was defined using criteria based on the modified Borg scale/visual analogue scale and oxygen saturation changes after mask removal. Clinical and ventilatory variables were compared between patients with and without DVS. Results Sixty-five patients were included. DVS was identified in 21 patients (32.3%). Patients with DVS had greater dyspnoea intensity after NIV discontinuation and more often reported dyspnoea lasting more than one hour, immediate discomfort after mask removal and dyspnoea-related limitation of daily functioning. Achieved pressure support was higher in the DVS group than in patients without DVS (15.26 ± 4.78 vs 12.31 ± 3.68 cmH₂O; p=0.020). In exploratory logistic regression, higher achieved pressure support was associated with increased odds of DVS (OR 1.20 per 1 cmH₂O; 95% CI 1.02–1.41; p=0.031). BMI, Mallampati score, frailty, underlying diagnosis, NIV treatment duration and respiratory rate were not significantly associated with DVS. Conclusions DVS affected approximately one-third of patients receiving home NIV and was associated with substantial post-ventilation symptoms. Higher achieved pressure support emerged as the main ventilatory correlate of DVS and requires further investigation.
Introduction Oral squamous cell carcinoma (OSCC) is the most prevalent malignancy of the oral cavity, carrying a disproportionately high burden in South Asia. Histopathological grade is a recognised prognostic marker, yet its relationship with cervical nodal involvement in OSCC of the gingivobuccal complex has not been adequately characterised in the Pakistani population. Material and methods This descriptive cross-sectional study enrolled 257 consecutive patients with biopsy-confirmed OSCC of the gingivobuccal complex. Histopathological grading was performed by a single accredited laboratory. Cervical nodal status was assessed clinically and by contrast-enhanced computed tomography, since not all patients underwent neck dissection. Results Mean age was 48.78 ± 16.62 years; 138 (53.70%) participants were male and 119 (46.30%) female. Clinically and radiologically detected cervical nodal involvement was present in 173 participants (67.32%). Poorly differentiated tumours were most frequent (38.9%), followed by well differentiated (31.5%), moderately differentiated (24.9%), and undifferentiated (4.7%). Nodal involvement was comparable in well and moderately differentiated tumours (58.02% and 53.12%) and rose sharply in poorly differentiated (81.00%) and undifferentiated tumours (91.67%), a difference that was highly statistically significant (p < 0.001). Neither age (p = 0.723) nor sex (p = 0.192) was significantly associated with nodal involvement. Conclusions Histopathological grade showed a strong association with cervical nodal involvement in OSCC of the gingivobuccal complex, whereas age and sex did not. Early diagnosis and grade-informed neck evaluation may help improve outcomes, although prospective multivariable studies are needed before these findings can guide routine practice.